These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7769211)

  • 1. Host defenses and susceptibility to infection in patients with diabetes mellitus.
    McMahon MM; Bistrian BR
    Infect Dis Clin North Am; 1995 Mar; 9(1):1-9. PubMed ID: 7769211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the DCCT trial. Implications for managing our patients with diabetes.
    Worrall G
    Can Fam Physician; 1994 Nov; 40():1955-60, 1963-5. PubMed ID: 7841827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal disease, diabetes, and immune response: a review of current concepts.
    Grant-Theule DA
    J West Soc Periodontol Periodontal Abstr; 1996; 44(3):69-77. PubMed ID: 9477864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus.
    Kim KW
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S11-7. PubMed ID: 15563959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
    Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control.
    Peleg AY; Weerarathna T; McCarthy JS; Davis TM
    Diabetes Metab Res Rev; 2007 Jan; 23(1):3-13. PubMed ID: 16960917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diabetes Control and Complications Trial Study: implications for the diabetic foot.
    DeFronzo RA; Reasner C
    J Foot Ankle Surg; 1994; 33(6):551-6. PubMed ID: 7894400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations sulfonylurea and insulin therapy in diabetes mellitus.
    Kabadi UM; Kabadi MM
    Compr Ther; 1995 Dec; 21(12):731-6. PubMed ID: 8789138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A better future for children with type 1 diabetes: Review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
    Morales A
    J Ark Med Soc; 2009 Oct; 106(4):90-3. PubMed ID: 19813399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery.
    Mohammadi S; Dagenais F; Mathieu P; Kingma JG; Doyle D; Lopez S; Baillot R; Perron J; Charbonneau E; Dumont E; Metras J; Desaulniers D; Voisine P
    Circulation; 2007 Sep; 116(11 Suppl):I220-5. PubMed ID: 17846307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions.
    Daoud AK; Tayyar MA; Fouda IM; Harfeil NA
    J Immunotoxicol; 2009 Mar; 6(1):36-41. PubMed ID: 19519161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental diabetes and anti-infection defenses in the organism. I. Metabolic modifications produced in vitro in the phagocytes of normal rabbits, at rest or active, by serum from diabetic rabbits].
    Henon M; Delaunay A
    Ann Inst Pasteur (Paris); 1968 Nov; 115(5):908-21. PubMed ID: 5701628
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes and infection: is there a link?--A mini-review.
    Knapp S
    Gerontology; 2013; 59(2):99-104. PubMed ID: 23182884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suppurative infection in diabetic patients].
    Myshkin KI; Slesarenko SS; Korzhenevich VI; Myshkin BK; Lupinovich TL
    Khirurgiia (Mosk); 1984 Apr; (4):22-5. PubMed ID: 6429409
    [No Abstract]   [Full Text] [Related]  

  • 19. Host defense mechanisms in diabetes mellitus.
    Axline SG
    Ariz Med; 1980; 37(6):428-30. PubMed ID: 7396749
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic host defenses in diabetic patients].
    Hauser GJ; Spirer Z
    Harefuah; 1980 Mar; 98(6):275-7. PubMed ID: 7409656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.